dichloroacetic acid has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, DT; Chuang, JL; Gui, WJ; Morlock, LK; Owens, KR; Qi, X; Scherer, PE; Tambar, UK; Tso, SC; Wernstedt-Asterholm, I; Williams, NS; Wu, CY; Wynn, RM | 1 |
| Bertelsen, LB; Bøgh, N; Hansen, ESS; Laustsen, C; Miller, J; Ringgaard, S; Wohlfart, P | 1 |
| Ball, V; Carr, CA; Clarke, K; Heather, LC; Johansson, E; Le Page, LM; Lewis, AJ; Rider, OJ; Tyler, DJ | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
4 other study(ies) available for dichloroacetic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Fatty Liver; HSP90 Heat-Shock Proteins; Humans; Isoenzymes; Isoindoles; Male; Mice; Mice, Obese; Obesity; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Sulfones | 2014 |
Concentration-dependent effects of dichloroacetate in type 2 diabetic hearts assessed by hyperpolarized [1-
Topics: Acetates; Animals; Bicarbonates; Diabetes Mellitus, Type 2; Dichloroacetic Acid; Heart; Magnetic Resonance Imaging; Pyruvic Acid; Rats | 2022 |
Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Dichloroacetic Acid; Echocardiography; Insulin; Lipids; Magnetic Resonance Spectroscopy; Male; Pyruvate Dehydrogenase Complex; Rats; Rats, Wistar | 2015 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |